Jonathan P S Knisely Selected Research

BRCA1 Protein

1/2021

BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan P S Knisely Research Topics

Disease

25	Neoplasms (Cancer) 06/2023 - 11/2002
17	Brain Neoplasms (Brain Tumor) 04/2024 - 01/2004
13	Meningioma (Meningiomas) 04/2024 - 05/2010
6	Neoplasm Metastasis (Metastasis) 01/2018 - 01/2007
4	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 11/2004
4	Glioma (Gliomas) 01/2023 - 11/2002
3	Adenocarcinoma 12/2015 - 06/2003
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2021
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 05/2008
2	Melanoma (Melanoma, Malignant) 08/2012 - 01/2007
2	Hypoxia (Hypoxemia) 11/2006 - 11/2002
2	Esophageal Neoplasms (Esophageal Cancer) 03/2006 - 06/2003
1	Central Nervous System Neoplasms 07/2022
1	Astrocytoma (Pilocytic Astrocytoma) 01/2022
1	Oligodendroglioma 01/2022
1	Acoustic Neuroma (Acoustic Neurinoma) 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Cardiotoxicity 01/2021
1	Vascular Neoplasms (Neoplasms, Vascular) 01/2021
1	Margins of Excision 12/2015
1	Hemorrhage 12/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2015
1	Anorexia 12/2015
1	Pituitary Neoplasms (Pituitary Adenoma) 07/2014
1	Leukoencephalopathies 05/2012
1	Glomus Jugulare Tumor 12/2010
1	Gallbladder Neoplasms (Gallbladder Cancer) 09/2008
1	Brain Injuries (Brain Injury) 04/2006
1	Inflammation (Inflammations) 04/2006
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2003
1	Hyperthermia 11/2002

Drug/Important Bio-Agent (IBA)

4	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2024 - 10/2020
4	gallium Ga 68 dotatateIBA 10/2023 - 10/2020
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 10/2020
2	GalliumIBA 04/2024 - 01/2022
2	RadiumIBA 01/2022 - 12/2020
2	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2021
2	AntigensIBA 01/2019 - 12/2015
2	Thalidomide (Thalomid)FDA Link 05/2008 - 05/2008
2	Oxygen (Dioxygen)IBA 11/2006 - 11/2002
1	Biomarkers (Surrogate Marker)IBA 03/2024
1	LigandsIBA 10/2023
1	Cesium-131IBA 06/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	cyclo(Arg-Pro) (CI 4)IBA 01/2022
1	AcidsIBA 01/2022
1	Lomustine (CCNU)FDA Link 01/2022
1	Procarbazine (Matulane)FDA Link 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2022
1	somatostatin receptor 2IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	BRCA1 ProteinIBA 01/2021
1	mesoglycanIBA 12/2020
1	Indium-111IBA 10/2020
1	Octreotide (Sandostatin)FDA LinkGeneric 10/2020
1	Capecitabine (Xeloda)FDA Link 12/2015
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 07/2014
1	Growth Hormone (Somatotropin)IBA 07/2014
1	Adrenocorticotropic Hormone (ACTH)FDA Link 07/2014
1	ProlactinIBA 07/2014
1	Phenobarbital (Luminal)FDA Link 05/2013
1	IpilimumabIBA 08/2012
1	CatecholaminesIBA 12/2010
1	Indicators and Reagents (Reagents)IBA 11/2006
1	carbamylated erythropoietinIBA 04/2006
1	CytokinesIBA 04/2006
1	Erythropoietin FDA Link 04/2006
1	prinomastat (Ag3340)IBA 03/2006
1	Metalloproteases (Metalloproteinases)IBA 03/2006
1	Matrix Metalloproteinase InhibitorsIBA 03/2006
1	Hemoglobins (Hemoglobin)IBA 11/2004
1	Fluorouracil (Carac)FDA LinkGeneric 06/2003
1	Cisplatin (Platino)FDA LinkGeneric 06/2003
1	Antineoplastic Agents (Antineoplastics)IBA 11/2002

Therapy/Procedure

24	Radiotherapy 10/2023 - 06/2003
9	Therapeutics 10/2023 - 11/2002
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2002
4	Immunotherapy 01/2023 - 01/2018
2	Brachytherapy 06/2023 - 07/2022
2	Re-Irradiation 01/2023 - 01/2023
2	Particle Accelerators 01/2023 - 12/2021
2	Combined Modality Therapy 01/2022 - 03/2006
2	Aftercare (After-Treatment) 01/2021 - 12/2010
2	Precision Medicine 01/2018 - 01/2018
2	Cranial Irradiation 01/2018 - 05/2008
2	Chemoradiotherapy 12/2015 - 06/2003
1	Craniotomy 01/2022
1	Contraindications 01/2022
1	Adjuvant Chemoradiotherapy 12/2015
1	Conformal Radiotherapy 05/2010
1	Neoadjuvant Therapy 06/2003